Approval · Notice of Compliance 11060 · 2010
FLUNAZINE: Notice of Compliance 11060
Issued February 19, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11060
- Date
- February 19, 2010
- Company
- Bimeda-MTC Animal Health Inc.Cambridge, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Additional indication
- Therapeutic class
- Anti-inflammatory, analgesic, antipyretic
- Canadian reference product
- BANAMINE (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUNAZINE | 02240510 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML